A detailed history of Awm Investment Company, Inc. transactions in Benitec Biopharma Inc. stock. As of the latest transaction made, Awm Investment Company, Inc. holds 625,000 shares of BNTC stock, worth $6.78 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares
625,000
Holding current value
$6.78 Million
% of portfolio
0.67%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$4.78 - $10.47 $2.99 Million - $6.54 Million
625,000 New
625,000 $4.37 Million

Others Institutions Holding BNTC

About Benitec Biopharma Inc.


  • Ticker BNTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,809,500
  • Market Cap $280M
  • Description
  • Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal...
More about BNTC
Track This Portfolio

Track Awm Investment Company, Inc. Portfolio

Follow Awm Investment Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Awm Investment Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Awm Investment Company, Inc. with notifications on news.